Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review ; volume:16 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-5 ; date:12.2018
Hereditary cancer in clinical practice ; 16, Heft 1 (27.4.2018), 1-5, 12.2018
- Creator
-
Sæther, Nikolai Havn
- Contributor
-
Skuja, Elina
Irmejs, Arvids
Maksimenko, Jelena
Miklasevics, Edvins
Purkalne, Gunta
Gardovskis, Janis
SpringerLink (Online service)
- DOI
-
10.1186/s13053-018-0092-2
- URN
-
urn:nbn:de:101:1-2018070115334677829604
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sæther, Nikolai Havn
- Skuja, Elina
- Irmejs, Arvids
- Maksimenko, Jelena
- Miklasevics, Edvins
- Purkalne, Gunta
- Gardovskis, Janis
- SpringerLink (Online service)
Other Objects (12)
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
Safety and feasibility of fasting in combination with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
Safety and feasibility of fasting in combination with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Speciation analysis of platinum-based chemotherapy drugs in human blood
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
Safety and feasibility of fasting in combination with platinum-based chemotherapy
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma